Botanical species · safety record

Terminalia arjuna

The EFSA Compendium of Botanicals holds 3 constituent measurements and 2 adverse-effect records for Terminalia arjuna. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Terminalia arjuna (Roxb. ex DC.) Wight & Arn.

3Constituent measurements

2Safety records

3Cited sources

92Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 92 licensed products naming Terminalia arjuna as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Aged bark
Bark
Bark (powder)
Bark dry extract
Bark extract
Branch bark
Leaf powder
Stem bark

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Stem / stalk	Solvent extraction	3.14 Percent	Phytochemical screening	Resolve DOI
Oxalates	Stem / stalk	Solvent extraction	4.38 Percent	Phytochemical screening	Resolve DOI
Saponins	Stem / stalk	Solvent extraction	2.11 Percent	Phytochemical screening	Resolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive: pancreas	Leaves	Solvent extraction	—	In vitro	No resolvable identifier
Reproductive	Uterus	Bark	Solvent extraction	Rat (as animal)	Reproduction toxicity	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Suely, A., Zabed, H., Ahmed, A B A., Mohamad, J., Nasiruddin, M., Sahu, J N., Ganesan, P. Toxicological and hematological effect of Terminalia arjuna bark extract on a freshwater catfish, Heteropneustes fossilis.. Fish physiology and biochemistry, 2016, vol. 42, no. 2, p. 431-44. DOI
Prakash, A.O. Biological evaluation of some medicinal plant extracts for contraceptive efficacy Future Aspects in Contraception. International Symposium. Heidelberg 5-8 September 1984. Contracept. deliv. syst., 1984, vol. 5, no. 3, p. 9.
Anam, K., Widharna, R. M., Kusrini, D. alpha-Glucosidase Inhibitor Activity of Terminalia Species. International journal of pharmacology, 2009, vol. 5, no. 4, p. 277-280.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature